Pasithea Therapeutics Announces Plans To Open Three New Clinics In The UK By Mid-2022
-- Each clinic expected to contribute an estimated USD$5 million (£4 million) annually in revenue --
-- New London locations will provide pharmacy services, ketamine therapy, and other psychiatric treatments, including repeated transcranial magnetic stimulation (“rTMS”) --
